CBRRF 10-K & 10-Q changes, risk factors and insider trading
Chain Bridge I (also CBGGF, CBRGF) · OTC · Blank Checks · CIK 1845149 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “Risks Associated with Acquiring and Operating a Business in Foreign Countries”
Largest changes
“As previously disclosed, on November 12, 2024, the Company received a letter from the Listing Qualifications Department of Nasdaq stating that, pursuant to Nasdaq Listing Rule IM-5101-2 (“Rule IM-5101-2”), the staff of Nasdaq (“Staff”) had determined that (i) the Company’s securities would be delisted from Nasdaq, (ii) trading of the Company’s Class A common stock and units would be suspended at the opening of business on November 19, 2024 and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration …”see in full comparison
“Risks Associated with Acquiring and Operating a Business in Foreign Countries”see in full comparison
Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by current or anticipatedsee in full comparisonanticipatedmilitary conflict, including between Russia and Ukraine and the conflictbetweeninIsraeltheandMiddleHamas,East, terrorism, sanctions, changes to foreign trade policies or other geopolitical events globally, a pandemic,includingandnew variant strains of the COVID-19 virus, andthe status of debt and equity markets.
see in full comparisonRisks Associated with Acquiring and Operating a Business in Foreign CountriesIf we pursue a partner company with operationsoperationsor opportunities outside of the United States for our initial business combination, we may face additional burdens in connection withwithinvestigating, agreeing to and completing such initial business combination, and if we effect such initial business combination, we would be subject to a variety of additional risks that may negatively impact our operations.
On December 29, 2023 Fulton AC acquired 3,035,000 Class B Shares and private placement warrants to purchase 7,385,000 Class A Shares exercisable 30 days after the consummation of our initial business combination for a purchase price of $200,000. The Class B Shares are convertible into Class A Shares at the option of the holder. However, the Class A Shares issued upon such conversion will not participate in the liquidation of the trust account and may not be redeemed for a share of the trust account. In addition, Fulton AC made the Fulton AC loan of up to $1,500,000 to the Company which cannot be repaid from the trust account.see in full comparisonAs of December 31, 2024, there is no outstanding balance on the Fulton AC loan.The Fulton AC loan was exchanged for the Exchange Note. The Exchange Note is substantiallyconvertiblesimilarintotowarrantsthewhichFultonareACnotNote,exercisableexceptuntilthat30(i)daystheaftergoverning law and jurisdiction was changed from New York to Delaware; (ii) the maturity date was extended to the later of (x) June 29, 2025 and (y) the consummation ofanthe Company’s initialbusinessBusinesscombination.Combination; and (iii) the holder may exchange the Exchange Note, in whole or in part, to satisfy the purchase price of securities sold by the Company in a subsequent offering, if any, in whole or in part, at a premium of 35%. At this time the Company does not have any agreements, written or oral, for any subsequent offering of Company securities. No new consideration was paid in conjunction with the Exchange. If we do not consummate an initial business by November 15,2025, the2026, all warrants held or into which the Fulton AC loan is convertible (and the underlying securities) will expire worthless. In addition, if we do not complete our initial business combination, we will not repay the Fulton AC loan from the trust account, and we would likely not have other available funds to repay the Fulton AC loan. The interests of Fulton AC and its equity holders may influence their motivation in identifying and selecting a partner business combination, completing an initial business combination and influencing the operation of the business following the initial business combination.
Although we believe thatsee in full comparisonthatthe net proceeds of the Initial Public Offering and the sale of the private placement warrants and the proceeds from the Fulton AC loan will be sufficient to allow us to complete our initial business combination, because we have not yet selected any prospective partner business we cannot ascertain the capital requirements for any particular transaction. If the net proceeds of the Initial Public Offering and the sale of the private placement warrants and the proceeds from the Fulton AC loan prove to be insufficient, either because of the size of our initial business combination, the depletion of the available net proceeds in search of a partner business, the obligation to redeem for cash a significant number of shares from shareholders who elect redemption in connection with our initial business combination or the terms of negotiated transactions to purchase shares in connection with our initial business combination, we may be required to seek additional financing or to abandon the proposed business combination. Such financing may not be available on acceptable terms, if at all. The current economic environment may make difficult for companies to obtain acquisition financing. To the extent that additional financing proves to be unavailable when needed to complete our initial business combination, we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative partner business candidate. If we do not complete our initial business combination within the required time period, our public shareholders may, as ofJuneMarch16,27,2025,2026, receive only approximately$11.88$12.37 per public share, or less in certain circumstances, on the liquidation of our trustaccount andaccount, our warrants will expireworthless.and assets of the Company, other than cash in the trust account, will be used, first, in satisfaction of outstanding obligations to lenders (including, without limitation, under certain circumstances, Fulton AC and CB Co-Investment, and other creditors of the Company) and thereafter, if any cash remains available, distributed to our shareholders. However, if we do not complete our initial business combination, we would likely not have other available funds to repay such lenders and creditors. The Company does not expect there to be additional funds to be distributed to shareholders. Any other cash held by the Company other than funds in the trust account, will be used first to pay outstanding bills and loans. In addition, even if we do not need additional financing to complete our initial business combination, we may require such financing to fund the operations or growth of the partner business. The failure to secure additional financing could have a material adverse effect on the continued development or growth of the partner business. None of Fulton AC or our executive officers, directors or shareholders is required to provide any financing to us in connection with or after our initial business combination.
Full comparison: every changed paragraph (51)
Furthermore, in no event
will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not then
become subject to the SEC’s “penny stock” rules). Consequently, if accepting all properly submitted redemption requests
would cause our net tangible assets to be less than $5,000,001 or such greater amount necessary to satisfy a closing condition as described
above, we would not proceed with such redemption and the related business combination and may instead search for an alternate business
combination. Prospective partners will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction
with us.
We may not hold a shareholder
vote to approve our initial business combination unless the business combination would require shareholder approval under applicable Cayman
Islands law, our thirdfourth amended and restated memorandum and articles of association, or stock exchange listing requirements or if we decide
to hold a shareholder vote for business or other reasons.
If we seek shareholder approval of
our initial
business combination, Fulton AC, CBG, CB-CoCB InvestmentCo-Investment and our current and former directors and officers have agreed to vote
in favor
of such initial business combination, regardless of how our public shareholders vote.
Our thirdfourth amended and restated
memorandum and articles of association provides that, if we seek shareholder approval, we will complete our initial business combination
only if we receive approval pursuant to an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority
of the shareholders who are entitled to attend and vote at a general meeting of the Company. Fulton AC, CBG, CB Co-Investment and our
current and former directors and officers have agreed to vote their Class B Shares and Class A Shares and any public shares purchased
during or after the Initial Public Offering in favor of our initial business combination, together constituting 83.84%96.7% of the Ordinary
Shares currently outstanding. Accordingly, if we seek shareholder approval of our initial business combination, the agreement by Fulton
AC, CBG, CB-CoCB InvestmentCo-Investment and our current and former directors and officers to vote in favor of our initial business combination will
result in the requisite shareholder approval for such initial business combination.
At the time of your investment in
us, you will
not be provided with an opportunity to evaluate the specific merits or risks of any partner businesses. Since our Board may
complete a
business combination without seeking shareholder approval, public shareholders may not have the right or opportunity to vote
on the business
combination, unless we seek such shareholder approval. Accordingly, your only opportunity to affect the investment decision regarding
regarding a potential business combination may be limited to exercising your redemption rights within the period of time (which will be
at least
20 business days) set forth in our tender offer documents mailed to our public shareholders in which we describe our initial business
businesscombination. combination.TheThe ability of our public shareholders to exercise redemption rights with respect to a large number of our shares
may not
allow us to complete the most desirable business combination or optimize our capital structure.
Our search for a business combination,
and any
target business with which we ultimately consummate a business combination, may be materially adversely affected by current or anticipated
anticipated military conflict, including between Russia and Ukraine and the conflict betweenin Israelthe andMiddle Hamas,East, terrorism, sanctions, changes
to foreign
trade policies or other geopolitical events globally, a pandemic, includingand new variant strains of the COVID-19 virus, and
the status of debt and equity markets.
Our ability to consummate
a business
combination may be dependent on our ability to raise equity and debt financing which may be impacted by current or anticipated military
military conflict, including between Russia and Ukraine and the conflict betweenin Israelthe andMiddle Hamas,East, terrorism, sanctions, the pandemics
and other events,
including as a result of increased market volatility, decreased market liquidity and third-party financing being unavailable
on terms
acceptable to us or at all. Economic uncertainty in various global markets caused by political instability may result in weakened demand
demand for products sold by potential target businesses and difficulty in forecasting financial results on which we rely in the evaluation of
of potential target businesses. Global conflicts, including the military conflict between Russia and Ukraine, as well as economic sanctions
implemented by the United States and European Union against Russia in response thereto, may negatively impact markets, increase energy
and transportation costs and cause weaker macro-economic conditions. Political developments impacting government spending and international
trade, including inflation, raising interest rates, recently enacted and threatened tariffs, may also negatively impact markets and cause
weaker macro-economic conditions. The effect of any or all of these events could adversely impact our ability to find a suitable business
combination, as it may affect demand for potential target companies’ products or the cost of manufacturing thereof, harm their operations
and weaken their financial results.
We may not be able to find
a suitable partner business and consummate an initial business combination by November 15, 2025.2026. Our ability to complete our initial business
combination may be negatively impacted by general market conditions, volatility in the capital and debt markets and the other risks described
herein. If we have not consummated an initial business combination within such applicable time period, we will: (i) cease all operations
except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the
public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000 of
interest to pay dissolution expenses),any, divided by the number
of the then-outstanding public shares, which redemption will completely extinguish
public shareholders’ rights as shareholders (including
the right to receive further liquidation distributions, if any); and (iii)
as promptly as reasonably possible following such redemption,
subject to the approval of our remaining shareholders and our Board, liquidate
and dissolve, subject in the case of clauses (ii) and (iii),
to our obligations under Cayman Islands law to provide for claims of creditors
and the requirements of other applicable law. Our third fourth
amended and restated memorandum and articles of association provides that, if
we wind up for any other reason prior to the consummation
of our initial business combination, we will follow the foregoing procedures
with respect to the liquidation of the trust account as promptly
as reasonably possible but not more than ten business days thereafter,
subject to applicable Cayman Islands law. In either such case,
our public shareholders may receive only $11.90$12.37 per public share, or less
than $11.90$12.37 per public share, on the redemption of their shares,
and our warrants will expire worthless. See “— If third parties
bring claims against us, the proceeds held in the trust account
could be reduced and the per-share redemption amount received by shareholders
may be less than $11.90$10.20 per public share” and other
risk factors herein.
Our public shareholders will
be entitled to receive funds from the trust account only upon the earlier to occur of: (i) our completion of an initial business combination,
and then only in connection with those Class A ordinary shares that such shareholder properly elected to redeem, subject to the limitations
described herein, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our thirdfourth
amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders
of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem
100% of our public shares if we do not complete our initial business combination by November 15, 20252026 or (B) with respect to any other
provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination activity, and (iii) the
redemption of our public shares if we have not consummated an initial business by November 15, 2025,2026, subject to applicable law and as
further described herein. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described
in clause (ii) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial
business combination or liquidation if we have not consummated an initial business combination by November 15, 2025,2026, with respect to such
Class A ordinary shares so redeemed. In no other circumstances will a shareholder have any right or interest of any kind to or in the
trust account. Holders of warrants will not have any right to the proceeds held in the trust account with respect to the warrants. Accordingly,
to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.
The longer that the funds in
in the trust account are held in short-term U.S. government treasury obligations or in money market funds invested exclusively in such securities,
securities, the greater the risk that we may be considered an unregistered investment company. To mitigate the risk of us being deemed
to be an unregistered
investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and
thus subject to regulation
under the Investment Company Act, we may, at any time, instruct the trustee with respect to the trust account
to liquidate the U.S. government
treasury obligations or money market funds held in the trust account and thereafter to hold all funds
in the trust account in cash until
the earlier of consummation of an initial business combination or liquidation of the Company. Following
such liquidation of the securities
held in the trust account, we would likely receive minimal interest, if any, on the funds held in the
trust account .account. However, interest
previously earned on the funds held in the trust account still may be released to us to pay our taxes,
if any, and certain other expenses
as permitted. As a result, any decision to liquidate the securities held in the trust account and thereafter
to hold all funds in the
trust account in cash would reduce the dollar amount the public shareholders would receive upon any redemption
or liquidation of the Company.
As of the date of this proxy statement, we have not yet made any such determination to liquidate the securities
held in the trust account.
The Company’s securities have been delisted
delisted from trading on Nasdaq and currently trade on the OTC Markets,OTCID, which may adversely affect the flexibility of investors’
to resell their
securities in the secondary market.
As previously disclosed, on November 12, 2025, the Company received a written notice from the OTC Markets Group (“OTC”) notifying the Company that, because the Company’s public float as it was then displayed on the Company profile was less than 10% of the total shares outstanding, the Company was not in compliance with the public float requirement for continued listing on OTCQB Venture Market (“OTCQB”), as set forth in Section 2 of the OTCQB listing.
On February 11, 2026, the Company received a written notice from OTC indicating that the cure period had expired. Consequently, the Company’s securities were moved from OTCQB.
As previously disclosed,
on November 12, 2024, the Company received a letter from the Listing Qualifications Department of Nasdaq stating that, pursuant to Nasdaq
Listing Rule IM-5101-2 (“Rule IM-5101-2”), the staff of Nasdaq (“Staff”) had determined that (i) the Company’s
securities would be delisted from Nasdaq, (ii) trading of the Company’s Class A common stock and units would be suspended at the
opening of business on November 19, 2024 and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission, which will
remove the Company’s securities from listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose acquisition company
must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement.
Since the Company failed to complete its initial business combination by November 4, 2024, the Staff concluded that the Company did not
comply with Rule IM-5101-2 and that the Company’s securities were subject to delisting. The Company’s securities were subsequently
delisted from Nasdaq.
Following the suspension
of trading
on Nasdaq,OTCQB, the Company’s Class A ordinary shares began trading on OTCQBOTCID under the symbol “CBRRFCBRRF.” on The Company’s
warrants and units beganalso tradingtrade on the Expert Market operated by OTCOTCID under the symbols “CBRGF” and “CBGGF,” respectively.
TheOTCID OTC Expert Market and
OTCQB areis significantly more limited markets
than Nasdaq,Nasdaq or OTCQB, and quotation on the OTC Expert Market or OTCQBOTCID will likely result in a less
liquid market for existing and potential holders of the Company’s
Class A ordinary shares to trade such securities and could further
depress the trading price of the Class A ordinary shares. The Company
can provide no assurance that its securities will continue to trade
on this market, whether broker-dealers will continue to provide public
quotes of its securities on this market, or whether the trading
volume of its Class A ordinary shares will be sufficient to provide for
an efficient trading market for existing and potential holders
of its Class A ordinary shares.
Trading on the OTC Expert
Market or OTCQBOTCID could also harm
the Company’s ability to raise capital through alternative financing sources on terms acceptable
to us, or at all, and may result
in the loss of confidence in the Company’s financial stability by suppliers, customers and employees.
Investors would likely find
it more difficult to dispose of, or to obtain accurate market quotations for, the Class A ordinary shares,
as the liquidity that Nasdaq
provides would no longer be available to investors.
If we seek shareholder approval
of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to
the tender offer rules, our thirdfourth amended and restated memorandum and articles of association provides that a public shareholder, together
with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group”
(as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an
aggregate of 15% of the shares sold in the Initial Public Offering, which we refer to as the “Excess Shares,” without our
prior consent. However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares)
for or against our initial business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability
to complete our initial business combination and you could suffer a material loss on your investment in us if you sell Excess Shares in
open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete
our initial business combination. And as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose
of such shares, would be required to sell your shares in open market transactions, potentially at a loss.
Because of our limited resources and the
increased competition for
business combination opportunities, it may be more difficult for us to complete our initial business combination.
If we do not complete
our initial business combination within the required time period, our public shareholders may, as of JuneMarch 16,27, 2025, 2026,
receive only approximately
$11.88 $12.37 per public share, or less in certain circumstances, on the liquidation of our trust account and our
warrants will expire worthless.
If the funds not being held in the
trust account
are insufficient to allow us to operate until November 15, 2025,2026, it could limit the amount available to fund our search
for a partner
business or businesses and complete our initial business combination, and we will depend on loans from Fulton AC and C/M Lender to fund
our search and to complete our initial business combination.
Only up to $1,500,000$1,131,320 from the
theExchange FultonNote ACand loan$16,382 cash in our bank account is available to us as of March 27, 2026 outside the trust account to fund our working
capital requirements. We believe that these funds
will be sufficient to allow us to operate for at least until November 15, 20252026; however,
our estimate may not be accurate. If we are required
to seek additional capital, we would need to borrow funds from Fulton AC, members
of our team or any of their affiliates or other third
parties to operate or may be forced to liquidate. Fulton AC, our directors and officers
or any of their affiliates are under no obligation
to advance funds to us in such circumstances. Of the funds available to us, we expect
to use a portion of the funds available to us to
pay fees to consultants to assist us with our search for a partner business. We could
also use a portion of the funds as a down payment
or to fund a “no-shop” provision (a provision in letters of intent designed
to keep partner businesses from “shopping”
around for transactions with other companies or investors on terms more favorable
to such partner businesses) with respect to a particular
proposed business combination, although we do not have any current intention
to do so. If we entered into a letter of intent where we
paid for the right to receive exclusivity from a partner business and were subsequently
required to forfeit such funds (whether as a result
of our breach or otherwise), we might not have sufficient funds to continue searching
for, or conduct due diligence with respect to, a
partner business.
Any advances of funds to
us by Fulton AC, C/M Lender, our directors or officers
or their affiliates, may be repaid only from funds held outside the trust account
or from funds released to us upon completion of our
initial business combination. The FultonExchange AC loanNote of $1,500,000 may be convertible into
warrants of the post-business combination entity
at a price of $1.00 per warrant at the option of the lender. The warrants would be identical
to the private placement warrants. Prior
to the completion of our initial business combination, we do not expect to seek loans from parties
other than Fulton AC, C/M Lender, or our officers
or directors or any of their affiliates as we do not believe third parties will be willing
to loan such funds and provide a waiver against
any and all rights to seek access to funds in our trust account. If we do not complete
our initial business combination within the required
time period because we do not have sufficient funds available to us, we will be forced
to cease operations and liquidate the trust account.
Consequently, our public shareholders may, as of JuneMarch 16,27, 20252026 only receive an estimated $11.88
$12.37 per public share, or possibly less, on
our redemption of our public shares, and our warrants will expire worthless. See “—
If third parties bring claims against
us, the proceeds held in the trust account could be reduced and the per-share redemption amount
received by shareholders may be less than
$11.88 $10.20 per public share” and other risk factors herein.
In the event that the proceeds
in the trust account are reduced below the lesser of (i) $11.88$10.20 per public share and (ii) the actual amount per share held in the trust
account as of the date of the liquidation of the trust account if less than $11.88$10.20 per public share due to reductions in the value of
the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, and if Fulton AC asserts that it
is is
unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our
independent independent
directors would determine whether to take legal action against Fulton AC to enforce its indemnification obligations. While
we currently
expect that our independent directors would take legal action on our behalf against Fulton AC to enforce its indemnification
obligations obligations
to us, it is possible that our independent directors in exercising their business judgment and subject to their fiduciary
duties may choose
not to do so in any particular instance. If our independent directors choose not to enforce these indemnification obligations,
the amount
of funds in the trust account available for distribution to our public shareholders may be reduced below $11.88$10.20 per public
share.
If we do not consummate an initial
initial business combination by November 15, 2025,2026, the proceeds then on deposit in the trust account, including interest earned on the
funds held
in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to
pay dissolution
expenses), will be used to fund the redemption of our public shares, as further described herein. Any redemption of public shareholders
shareholders from the trust account will be effected automatically by function of our thirdfourth amended and restated memorandum and articles
of association
prior to any voluntary winding up. If we are required to wind up, liquidate the trust account and distribute such amount
therein, pro
rata, to our public shareholders, as part of any liquidation process, such winding up, liquidation and distribution must
comply with the
applicable provisions of the Companies Act. In that case, investors may be forced to wait beyond November 15, 20252026 before
the redemption
proceeds of our trust account become available to them, and they receive the return of their pro rata portion of the proceeds
from our
trust account. We have no obligation to return funds to investors prior to the date of our redemption or liquidation unless,
prior thereto,
we consummate our initial business combination or amend certain provisions of our thirdfourth amended and restated memorandum
and articles
of association, and only then in cases where investors have sought to redeem their Class A ordinary shares. Only upon our
redemption or
any liquidation will public shareholders be entitled to distributions if we do not complete our initial business combination
and do not
amend certain provisions of our thirdfourth amended and restated memorandum and articles of association. Our thirdfourth amended and restated memorandum
memorandum and articles of association provides that, if we wind up for any other reason prior to the consummation of our initial business combination,
combination, we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible
but not
more than ten business days thereafter, subject to applicable Cayman Islands law.
In accordance with OTCQBOTCID corporate
corporate governance requirements and our thirdfourth amended and restated memorandum and articles of association, we are not required to hold
an annual
general meeting until no later than one year after our first fiscal year end following our listing on OTCQB.OTCID. As an exempted
company, there
is no requirement under the Companies Act for us to hold annual or extraordinary general meetings to appoint directors.
Until we hold
an annual general meeting, public shareholders may not be afforded the opportunity to appoint directors and to discuss company affairs
affairs with our team. Our Board is divided into three classes with only one class of directors being appointed in each year and each
class (except
for those directors appointed prior to our first annual general meeting) serving a three-year term.
We may pursue business combination
opportunities in any sector, except that we will not, under our thirdfourth amended and restated memorandum and articles of association, be
permitted to effectuate our initial business combination solely with another blank check company or similar company with nominal operations.
Because we have not yet selected or approached any specific partner business with respect to a business combination, there is no basis
to evaluate the possible merits or risks of any particular partner business’s operations, results of operations, cash flows, liquidity,
financial condition or prospects. To the extent we complete our initial business combination, we may be affected by numerous risks inherent
in the business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking
an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable
or a development stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular partner
business, we may not properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due
diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances
that those risks will adversely impact a partner business. An investment in our units may not ultimately prove to be more favorable
to investors than a direct investment, if such opportunity were available, in a business combination partner. Accordingly, any holders
who choose to retain their securities following our initial business combination could suffer a reduction in the value of their securities.
Such holders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was
due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully
bring a private claim under securities laws that the proxy solicitation or tender offer materials, as applicable, relating to the business
combination contained an actionable material misstatement or material omission.
We may issue additional Class A ordinary
ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after completion
of our initial
business combination. We may also issue Class A ordinary shares upon the conversion of the Class B Shares at a ratio
greater than
one-to-one at the time of our initial business combination as a result of the anti-dilution provisions contained in our thirdfourth amended
amended and restated memorandum and articles of association. Any such issuances would dilute the interest of our shareholders and likely present
present other risks.
Our thirdfourth amended and restated
memorandum and articles of association
authorizes the issuance of up to 479,000,000 Class A ordinary shares, par value $0.0001 per share,
20,000,000 Class B ordinary shares,
par value $0.0001 per share, and 1,000,000 preference shares, par value $0.0001 per share. As of the
close of business on JuneMarch 16,27, 2025,
2026, there were 2,985,029476,381,265 and 3,191,00016,809,000 authorized but unissued Class A ordinary shares and Class B
ordinary shares, respectively, available
for issuance which amount includes shares reserved for issuance upon exercise of outstanding
warrants or shares issuable upon conversion
of the Class B ordinary shares, if any. The Class B ordinary shares are automatically convertible
into Class A ordinary shares at the
time of our initial business combination as described herein and in our thirdfourth amended and restated
memorandum and articles of association.
There are no preference shares issued and outstanding. These amounts exclude any private placement
warrants that may be issued upon conversion
of the CB Co-Investment loan and extension loans.
We may issue a substantial number
number of additional Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive
plan after completion of our initial business combination. We may also issue Class A ordinary shares to redeem the warrants as described
in the section entitled “Warrants — Public Shareholders’ Warrants — Redemption of
warrants warrants
for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00” in Exhibit 4.5 of this
Annual Report
on Form 10-K or upon conversion of the Class B ordinary shares at a ratio greater than one-to-one at the time of our initial
business business
combination as a result of the anti-dilution provisions as set forth herein. However, our thirdfourth amended and restated memorandum
and articles
of association provides, among other things, that prior to the completion of our initial business combination, we may not
issue additional
shares that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote on any initial
business combination
or on any other proposal presented to shareholders prior to or in connection with the completion of an initial business
combination. These
provisions of our thirdfourth amended and restated memorandum and articles of association, like all provisions of our third fourth
amended and restated
memorandum and articles of association, may be amended with a shareholder vote. The issuance of additional ordinary
or preference shares:
Fulton AC, CBG, CB-CoCB InvestmentCo-Investment and
our current
and former directors and officers may receive additional Class A ordinary shares if we issue shares to consummate an initial business
business combination.
The outstanding Class B Shares
will automatically convert into Class A ordinary shares on the first business day following the consummation of our initial business combination
at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Class B Shares will equal, in the aggregate,
on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial
Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion
or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the
consummation of the initial business combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or
convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial business combination and
any private placement warrants issued to CBG or CB Co-Investment, members of our team or any of their affiliates upon conversion of the
CB Co-Investment loan, the extension loans and working capital loans. In no event will the Class B ordinary shares convert into Class
A ordinary shares at a rate of less than one to one. As of February 7, 2024, CBG and CB-CoCB InvestmentCo-Investment had converted all of their outstanding
Class B ordinary shares into Class A ordinary shares on a one-for-one basis.basis, other than 25,000 shares of Class B ordinary shares held
by CBG. The Class A ordinary shares issued upon such conversion are
not entitled to participate in the distribution of funds held in the
trust account.
In addition, Fulton AC and our
our directors and officers expect in the future to become affiliated with other public blank check companies that may have acquisition objectives
objectives that are similar to ours. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity
opportunity should be presented. These conflicts may not be resolved in our favor and a potential partner business may be presented to
such other
blank check companies, prior to its presentation to us, subject to our officers’ and directors’ fiduciary duties
under Cayman
Islands law. Our thirdfourth amended and restated memorandum and articles of association provides that we renounce our interest
in any business
combination opportunity offered to any director or officer unless such opportunity is expressly offered to such person
solely in his or
her capacity as a director or officer of the company and it is an opportunity that we are able to complete on a reasonable
basis.
On December 29, 2023 Fulton
AC acquired 3,035,000 Class B Shares and private placement warrants to purchase 7,385,000 Class A Shares exercisable 30 days after the
consummation of our initial business combination for a purchase price of $200,000. The Class B Shares are convertible into Class A Shares
at the option of the holder. However, the Class A Shares issued upon such conversion will not participate in the liquidation of the trust
account and may not be redeemed for a share of the trust account. In addition, Fulton AC made the Fulton AC loan of up to $1,500,000 to
the Company which cannot be repaid from the trust account. As of December 31, 2024, there is no outstanding balance on the Fulton AC loan.
The Fulton AC loan was exchanged for the Exchange Note. The Exchange Note is
substantially convertiblesimilar intoto warrantsthe whichFulton areAC notNote, exercisableexcept untilthat 30(i) daysthe aftergoverning law and jurisdiction was changed from New York to Delaware;
(ii) the maturity date was extended to the later of (x) June 29, 2025 and (y) the consummation of anthe Company’s initial businessBusiness
combination.Combination; and (iii) the holder may exchange the Exchange Note, in whole or in part, to satisfy the purchase price of securities sold
by the Company in a subsequent offering, if any, in whole or in part, at a premium of 35%. At this time the Company does not have any
agreements, written or oral, for any subsequent offering of Company securities. No new consideration was paid in conjunction with the
Exchange. If we do not consummate an initial business by November 15, 2025, the2026, all warrants held or into which the Fulton AC loan
is convertible
(and the underlying securities) will expire worthless. In addition, if we do not complete our initial business combination,
we will not
repay the Fulton AC loan from the trust account, and we would likely not have other available funds to repay the Fulton AC
loan. The interests
of Fulton AC and its equity holders may influence their motivation in identifying and selecting a partner business
combination, completing
an initial business combination and influencing the operation of the business following the initial business combination.
We have funds available in
the amount of approximately $5,414,454,$1,920,220, as of JuneMarch 16,27, 2025,2026, assuming no redemptions that we may use to complete our initial business
combination.
Our thirdfourth amended and restated
restated memorandum and articles of association do not provide a specified maximum redemption threshold, except that in no event
will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not
then become subject to the SEC’s “penny stock” rules).threshold. As a result, we may be able to complete
our initial
business combination even though a substantial majority of our public shareholders do not agree with the transaction and have
redeemed their shares or, if we seek shareholder approval of our initial business combination and do not conduct redemptions in connection
connection with our initial business combination pursuant to the tender offer rules, have entered into privately negotiated
agreements to sell their
shares to Fulton AC or our officers, directors, advisors or any of their affiliates. In the event the
aggregate cash consideration we
would be required to pay for all Class A ordinary shares that are validly submitted for redemption
plus any amount required to satisfy
cash conditions pursuant to the terms of the proposed business combination exceed the aggregate
amount of cash available to us, we will
not complete the business combination or redeem any shares, all Class A ordinary shares
submitted for redemption will be returned to the
holders thereof, and we instead may search for an alternate business
combination.
In order to effectuate an initial
business combination,
blank check companies have, in the recent past, amended various provisions of their charters and other governing
instruments, including
their warrant agreements. We may seek to amend our thirdfourth amended and restated memorandum and articles of association
or governing instruments
in a manner that will make it easier for us to complete our initial business combination that our shareholders
may not support.
In order to effectuate a business
business combination, blank check companies have, in the recent past, amended various provisions of their charters and governing instruments, including
including their warrant agreements. For example, blank check companies have amended the definition of business combination, increased redemption
redemption thresholds, extended the time to consummate a business combination and, with respect to their warrants, amended their warrant agreements
agreements to require the warrants to be exchanged for cash and/or other securities. Amending our thirdfourth amended and restated memorandum
and articles
of association will require at least a special resolution of our shareholders as a matter of Cayman Islands law, meaning
the approval
of holders of at least two-thirdstwo-fourths of our ordinary shares who attend and vote at a general meeting of the company, and amending
our warrant
agreement will require a vote of holders of at least 50% of the public warrants and, solely with respect to any amendment
to the terms
of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants,
50% of the
number of the then outstanding private placement warrants. In addition, our thirdfourth amended and restated memorandum and articles
of association
will require us to provide our public shareholders with the opportunity to redeem their public shares for cash if we propose
an amendment
to our thirdfourth amended and restated memorandum and articles of association (A) that would modify the substance or timing of
our obligation
to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial
business combination
or to redeem 100% of our public shares if we do not complete our initial business combination by November 15, 2025
2026 or (B) with respect
to any other provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination activity.
activity. To the extent any of such amendments would be deemed to fundamentally change the nature of any of the securities offered through this
this registration statement, we would register, or seek an exemption from registration for, the affected securities.
The provisions of our thirdfourth amended
and restated
memorandum and articles of association that relate to our pre-business combination activity (and corresponding provisions
of the agreement
governing the release of funds from our trust account) may be amended with the approval of a special resolution which
requires the approval
of the holders of at least two-thirdstwo-fourths of our ordinary shares who attend and vote at a general meeting of the company,
which is a lower
amendment threshold than that of some other blank check companies. It may be easier for us, therefore, to amend our third
fourth amended and
restated memorandum and articles of association to facilitate the completion of an initial business combination that some
of our shareholders
may not support.
Some other blank check companies
have a provision in their charter or constitutional documents which prohibits the amendment of certain of its provisions, including those
which relate to a company’s pre-business combination activity, without approval by a certain percentage of the company’s shareholders.
In those companies, amendment of these provisions typically requires approval by between 90% and 100% of the company’s shareholders.
Our thirdfourth amended and restated memorandum and articles of association provides that any of its provisions related to pre-business combination
activity (including the requirement to deposit proceeds of the Initial Public Offering and the sale of the private placement warrants
and the proceeds from the Fulton AC loan into the trust account and not release such amounts except in specified circumstances, and to
provide redemption rights to public shareholders as described herein) may be amended if approved by special resolution, meaning holders
of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, and corresponding provisions of
the trust agreement governing the release of funds from our trust account may be amended if approved by holders of at least 65% of our
ordinary shares; provided that the provisions of our thirdfourth amended and restated memorandum and articles of association governing the
appointment appointment
or removal of directors prior to our initial business combination may only be amended by a special resolution passed by holders
representing representing
at least two-thirds of our issued and outstanding Class B ordinary shares. Fulton AC, CBG, CB Co-Investment and our current
and former
directors and officers and their permitted transferees, if any, will participate in any vote to amend our thirdfourth amended and
restated memorandum
and articles of association and/or trust agreement and will have the discretion to vote in any manner they choose.
As a result, we may
be able to amend the provisions of our thirdfourth amended and restated memorandum and articles of association which govern
our pre-business
combination behavior more easily than some other blank check companies, and this may increase our ability to complete
a business combination
with which you do not agree. Our shareholders may pursue remedies against us for any breach of our thirdfourth amended
and restated memorandum
and articles of association.
Fulton AC and our
executive officers
and directors have agreed, pursuant to a written agreement with us, that they will not propose any amendment to
our thirdfourth amended and
restated memorandum and articles of association (A) that would modify the substance or timing of our
obligation to provide holders of
our Class A ordinary shares the right to have their shares redeemed in connection with our initial
business combination or to redeem 100%
of our public shares if we do not complete our initial business combination by November 15,
2025 2026 or (B) with respect to any other provision
relating to the rights of holders of our Class A ordinary shares or pre-initial
business combination activity; unless we provide our public
shareholders with the opportunity to redeem their Class A ordinary
shares upon approval of any such amendment at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in
the trust account, including interest earned on the funds held in the trust
account and not previously released to us to pay our
income taxes, if any, divided by the number of the then-outstanding public shares.
Our shareholders are not parties to, or third
party beneficiaries of, this agreement and, as a result, will not have the ability to pursue
remedies against Fulton AC or our
executive officers or directors for any breach of this agreement. As a result, in the event of a breach,
our shareholders would need
to pursue a shareholder derivative action, subject to applicable law.
Certain agreements, including
the letter agreement, as amended, among us and Fulton AC, CBG, CB-CoCB InvestmentCo-Investment and certain of our current and former officers and directors
may be amended without shareholder approval. These agreements contain various provisions that our public shareholders might deem to be
material. While we do not expect our Board to approve any amendment to any of these agreements prior to our initial business combination,
it may be possible that our Board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or
more amendments to any such agreement in connection with the consummation of our initial business combination. Any such amendments would
not require approval from our shareholders, may result in the completion of our initial business combination that may not otherwise have
been possible, and may have an adverse effect on the value of an investment in our securities.
Although we believe
that that
the net proceeds of the Initial Public Offering and the sale of the private placement warrants and the proceeds from the Fulton
AC loan
will be sufficient to allow us to complete our initial business combination, because we have not yet selected any
prospective partner
business we cannot ascertain the capital requirements for any particular transaction. If the net proceeds of the
Initial Public Offering
and the sale of the private placement warrants and the proceeds from the Fulton AC loan prove to be
insufficient, either because of the
size of our initial business combination, the depletion of the available net proceeds in search
of a partner business, the obligation
to redeem for cash a significant number of shares from shareholders who elect redemption in
connection with our initial business combination
or the terms of negotiated transactions to purchase shares in connection with our
initial business combination, we may be required to
seek additional financing or to abandon the proposed business combination. Such
financing may not be available on acceptable terms, if
at all. The current economic environment may make difficult for companies to
obtain acquisition financing. To the extent that additional
financing proves to be unavailable when needed to complete our initial
business combination, we would be compelled to either restructure
the transaction or abandon that particular business combination
and seek an alternative partner business candidate. If we do not complete
our initial business combination within the required time
period, our public shareholders may, as of JuneMarch 16,27, 2025,2026, receive only approximately
$11.88 $12.37 per public share, or less in certain
circumstances, on the liquidation of our trust account andaccount, our warrants will expire worthless.and assets of the Company, other than cash in the
trust account, will be used, first, in satisfaction of outstanding obligations to lenders (including, without limitation, under
certain circumstances, Fulton AC and CB Co-Investment, and other creditors of the Company) and thereafter, if any cash remains
available, distributed to our shareholders. However, if we do not complete our initial business combination, we would likely not
have other available funds to repay such lenders and creditors. The Company does not expect there to be additional funds to be
distributed to shareholders. Any other cash held by the Company other than funds in the trust account, will be used first to pay
outstanding bills and loans. In addition, even if we do not need additional financing to complete our initial business combination,
we may require such financing to
fund the operations or growth of the partner business. The failure to secure additional financing
could have a material adverse effect
on the continued development or growth of the partner business. None of Fulton AC or our
executive officers, directors or shareholders
is required to provide any financing to us in connection with or after our initial
business combination.
As of the close of business on
March June27, 16, 2025,2026, Fulton AC owned, on an
as-converted basis, an aggregate of approximately 95.11%52.21% of our issued and outstanding ordinary
shares. Accordingly, they may exert a
substantial influence on actions requiring a shareholder vote, potentially in a manner that you
do not support, including amendments to
our thirdfourth amended and restated memorandum and articles of association. If Fulton AC purchases
any Class A ordinary shares in the open
market or in privately negotiated transactions, this would increase their control. Neither Fulton
AC nor, to our knowledge, any of our
executive officers or directors, have any current intention to purchase additional securities, other
than as disclosed in this Annual
Report on Form 10-K. Factors that would be considered in making such additional purchases would include
consideration of the current trading
price of our Class A ordinary shares. In addition, our Board, whose members were elected by Fulton
AC as the majority holder of our Class
B shares, is and will be divided into three classes, each of which will generally serve for a term
of three years with only one class
of directors being elected in each year. We may not hold an annual general meeting to appoint new directors
prior to the completion of
our initial business combination, in which case all of the current directors will continue in office until
at least the completion of
the business combination. If there is an annual general meeting, as a consequence of our “staggered”
Board, only a minority
of the Board will be considered for election and Fulton AC, because of its ownership position, will control the
outcome, as only holders
of our Class B ordinary shares will have the right to vote on the election of directors and to remove directors
prior to our initial business
combination. Accordingly, Fulton AC will continue to exert control at least until the completion of our
initial business combination.
In addition, we have agreed not to enter into a definitive agreement regarding an initial business combination
without the prior consent
of Fulton AC.
Our thirdfourth amended and restated memorandum and
and articles of association designates the courts of the Cayman Islands or the federal district courts of the United States as the sole and
and exclusive forum for certain actions or proceedings that may be initiated by our shareholders, which could discourage claims or limit shareholders’
shareholders’ ability to make a claim against the Company, our directors, officers and employees.
Our thirdfourth amended and restated
memorandum and articles of association provides that, all internal corporate claims, including (i) any claim of (or based upon) a breach
of fiduciary duty owed by any current or former director, officer or other employee of the Company to the Company or its shareholders;
and (ii) any action asserting a claim arising pursuant to any provision of Cayman Islands law, the second amended and restated memorandum,
or the second amended and restated articles of association, shall be governed by the laws of the Cayman Islands and unless we consent
in writing to the selection of an alternative forum, the courts of the Cayman Islands are the sole and exclusive forum for any such internal
corporate claims brought by any shareholder against, or on behalf of, the Company and its affiliates or any of its current or former directors,
officers, or employees. Our thirdfourth amended and restated memorandum and articles of association will further provide that, unless the Company
consents in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive
forum for any causes of actions or suits asserting a claim arising under the U.S. Securities Act of 1933, as amended or the rules and
regulations promulgated thereunder. These exclusive forum provisions would not apply to (i) suits brought to enforce a duty or liability
created by the Exchange Act, which provides for exclusive jurisdiction of the United States federal courts; (ii) any other claim for which
the federal district courts of the United States of America are the sole and exclusive forum; or (iii) any action, proceeding or claim
against the Company arising out of or relating in any way to the warrant agreement, which will be brought and enforced in the courts of
the State of New York or the United States District Court for the Southern District of New York. These exclusive forum provisions may
limit the ability of our shareholders to bring a claim in a judicial forum that such shareholders find favorable for disputes with us
or our directors, officers, or employees, which may discourage such lawsuits against us and our directors, officers and employees. In
addition, these exclusive forum provisions may result in our shareholders incurring increased costs to bring a claim or action due to,
but not limited to, the shareholder’s physical location or knowledge of the applicable laws, when the courts of the Cayman Islands,
the federal district courts of the United States, the courts of the State of New York or the United States District Court for the Southern
District of New York, or an alternative forum, with our consent, is the sole and exclusive forum. Alternatively, if a court were to find
the choice of forum provisions contained in our thirdfourth amended and restated memorandum and articles of association to be inapplicable
or or
unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could
materially materially
adversely affect our business, financial condition, and operating results.
Our corporate affairs and the
the rights of shareholders are governed by our thirdfourth amended and restated memorandum and articles of association, the Companies Act (as the
the same may be supplemented or amended from time to time) and the laws of the Cayman Islands. We are also subject to the federal securities
laws of the United States. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary
responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the laws of the Cayman Islands. The
laws of the Cayman Islands are derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from English
common law, the decisions of whose courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights
of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are different from what they would be
under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body
of securities laws as compared to the United States, and certain states, such as Delaware, may have more fully developed and judicially
interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative
action in a Federal court of the United States. For a more detailed discussion of the principal differences between the provisions of
the Companies Act applicable to us and, for example, the laws applicable to companies incorporated in the United States and their shareholders,
see the section of Exhibit 4.5 of this Annual Report on Form 10-K captioned “Certain Differences in Corporate Law.”
Shareholders of Cayman Islands
exempted companies like the Company have no general rights under Cayman Islands law to inspect corporate records or to obtain copies of
the register of members of these companies. Our directors have discretion under our thirdfourth amended and restated memorandum and articles
of association to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders, but
are not obliged to make them available to our shareholders. Pursuant to the second amended and restated memorandum and articles of association
of the Company, shareholders may, by Ordinary Resolution, also resolve to make the Company’s records available to the Shareholders.
This may make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder motion or
to solicit proxies from other shareholders in connection with a proxy contest.
Provisions in our thirdfourth amended and restated
restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to
pay in
the future for our Class A ordinary shares and could entrench our team.
Our thirdfourth amended and restated
memorandum and articles of association contains provisions that may discourage unsolicited takeover proposals that shareholders may consider
to be in their best interests. These provisions include a staggered Board, the ability of the Board to designate the terms of and issue
new series of preference shares, and the fact that prior to the completion of our initial business combination only holders of our Class
B ordinary shares, which have been issued to our sponsor, are entitled to vote on the appointment of directors, which may make more difficult
the removal of our team and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices
for our securities.
Risks Associated with Acquiring and Operating a Business in Foreign Countries
Risks Associated with Acquiring and Operating
a Business in Foreign Countries If we pursue a partner company with operations
operations or opportunities outside of the United States for our initial business combination, we may face additional burdens in connection with
with investigating, agreeing to and completing such initial business combination, and if we effect such initial business combination,
we would
be subject to a variety of additional risks that may negatively impact our operations.
Management's Discussion & Analysis (MD&A)
New heading “Contractual Obligations”
New heading “Registration Rights and Shareholder Rights”
Removed heading “Class A Ordinary Shares Subject to Possible Redemption”
Removed heading “Net Income (Loss) Per Share”
Largest changes
“On September 30, 2025, the Company issued an unsecured, non-interest bearing promissory note (the “C/M Note”) to the C/M C/M Lender in the aggregate principal amount of $1,250,000, for an aggregate purchase price of $1,000,000. The C/M Note is due and payable in full on the maturity date, June 30, 2026; provided that, upon the occurrence of an event of default, the outstanding principal and any other amounts outstanding under the C/M Note will become due and payable without demand. The C/M Note may be prepaid at any time without penalty. …”see in full comparison
see in full comparisonOurThe Company’s liquidity needsupprior toDecember29,the2023consummationhadofbeenthe Initial Public Offering were satisfied through thecash receiptpayment of $25,000 from CBG and CB Co-Investment to cover for certain expenses on behalf of the Company in exchange for issuance offounderClassshares,B ordinary shares (as defined in Note 5) and a loan fromtherelated party of approximately$244,000$244,000.underThe Company fully repaid the Note(as defined herein) which was repaid in fullon November 17,2021,2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering,over-allotment,the Private Placement held outside of thetrustTrustaccountAccount and the issuance of theconvertibleConvertiblenotes. In addition, in order to finance transaction costs in connection with a Business Combination,Note, theSponsorAdditional ConvertibleorNotean affiliate ofand theSponsor,FultonorACcertainNote.ofOnthe Company’sDecemberofficers29,and2023,directorsFultonmay,ACbutagreedaretonot obligated to, provideloan the CompanyWorking Capital Loans (as defined in Note 5). In connection with the consummation of the transactions contemplated by the Securities Purchase Agreement, CB Co-Investment irrevocably agreedup toconvert the $1.15$1.5 millionloan (the “Conversion Amount”) by CB Co-Investmentpursuant to the FultonCompanyAC Note atanoconversioninterestprice of $1.00 per warrant, or 1,150,000 warrants. As of December 31, 2024,in thefairsamevalueformof converted loan was $4,600 which is included in contingently issuable private placement warrantsand on theaccompanyingsamebalance sheetterms asofthe Additional Convertible Note with CBG which was terminated on December31,29,2024.2023.
Full comparison: every changed paragraph (21)
As of December 31, 2024,2025, we had
cash of $129,598$390,255 and a working capital
deficit of $884,195.$808,537.
OurThe Company’s liquidity
needs upprior to
December 29,the 2023consummation hadof beenthe Initial Public Offering were satisfied through the cash receiptpayment of $25,000 from CBG and CB Co-Investment
to cover for certain expenses on
behalf of the Company in exchange for issuance of founderClass shares,B ordinary shares (as defined in Note 5) and
a loan from the related party of approximately $244,000$244,000. underThe Company fully repaid the Note
(as defined herein) which was repaid in full on November 17, 2021,2021. Subsequent to the consummation
of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the
Initial Public Offering,
over-allotment, the Private Placement held outside of the trustTrust accountAccount and the issuance of the convertibleConvertible notes. In addition, in order
to finance transaction costs in connection with a Business Combination,Note, the SponsorAdditional
Convertible orNote an affiliate ofand the Sponsor,Fulton orAC certainNote. ofOn the
Company’sDecember officers29, and2023, directorsFulton may,AC butagreed areto not obligated to, provideloan the Company Working Capital Loans (as defined in Note 5).
In connection with the consummation of the transactions contemplated by the Securities Purchase Agreement, CB Co-Investment irrevocably
agreedup to convert the $1.15$1.5 million loan (the “Conversion Amount”) by CB Co-Investmentpursuant to the
Fulton CompanyAC Note at ano conversioninterest price
of $1.00 per warrant, or 1,150,000 warrants. As of December 31, 2024,in the fairsame valueform of converted loan was $4,600 which is included in
contingently issuable private placement warrantsand on the accompanyingsame balance sheetterms as ofthe Additional Convertible Note with CBG which was terminated
on December 31,29, 2024.2023.
On May 9, 2024, the Company entered into the Exchange Agreement with Fulton, pursuant to which Fulton and the Company agreed to Exchange the Fulton AC Note for the Exchange Note. The Exchange Note is substantially similar to the Fulton AC Note, except that (i) the governing law and jurisdiction was changed from New York to Delaware; (ii) the maturity date was extended to the later of (x) June 29, 2025 and (y) the consummation of the Company’s initial Business Combination; and (iii) the holder may exchange the Exchange Note, in whole or in part, to satisfy the purchase price of securities sold by the Company in a subsequent offering, if any, in whole or in part, at a premium of 35%. At this time the Company does not have any agreements, written or oral, for any subsequent offering of Company securities. No new consideration was paid in conjunction with the Exchange. As of December 31, 2025 and 2024, the Company has an outstanding balance of $368,680 and $296,942, respectively, under the Exchange Note.
On June 26, 2024, Phytanix Bio (“Phytanix”) agreed to loan the Company $1,590,995, pursuant to an unsecured non - interest bearing promissory note (the “Bridge Financing Note”). The maturity date of the Bridge Financing Note is the later of (x) June 29, 2025 and (y) the consummation of the Company’s initial Business Combination. The Bridge Financing Note may not be repaid with funds from the trust account that the Company established for the benefit of its public holders. The proceeds from the Bridge Financing Note will be used (i) to pay off certain working capital loans issued by the Company to Fulton AC, (ii) to pay for certain fees and expenses incurred in connection with the transactions contemplated in the Bridge Financing Note and the Company’s initial Business Combination and (iii) for other general corporate purposes. As of December 31, 2025 and 2024, the outstanding balance under the Bridge Financing Note was $1,023,235 and $1,063,235, respectively, in the accompanying balance sheets.
On September 30, 2025, the Company issued an unsecured, non-interest bearing promissory note (the “C/M Note”) to the C/M C/M Lender in the aggregate principal amount of $1,250,000, for an aggregate purchase price of $1,000,000. The C/M Note is due and payable in full on the maturity date, June 30, 2026; provided that, upon the occurrence of an event of default, the outstanding principal and any other amounts outstanding under the C/M Note will become due and payable without demand. The C/M Note may be prepaid at any time without penalty. All payments due under the C/M Note rank junior to certain existing indebtedness of the Company and senior to all other indebtedness of the Company and its subsidiaries. The proceeds of the C/M Note will be used to pay for certain fees and expenses incurred in connection with the Company’s initial Business Combination and for other general corporate purposes. As of December 31, 2025 and 2024, the outstanding balance under the C/M Note was $1,078,066 and $0, respectively, in the accompanying balance sheets.
The Company has until November
15, 20252026 to consummate an initial Business Combination. If the Company has not consummated a Business Combination,Combination by November 15, 2026,
the Company must (a)
cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than
ten business days
thereafter, redeem the Public Shares; and (c) as promptly as reasonably possible following such redemption, subject
to the approval of the
Company’s remaining shareholders and the directors, liquidate and dissolve, subject in each case to its obligations
under Cayman
Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.
In connection with our assessment
of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of
Uncertainties about an Entity’s Ability to
Continue as a Going Concern,” the Company has determined that the liquidity condition
and the date for mandatory liquidation and
subsequent dissolution raises substantial doubt about the Company’s ability to continue
as a going concern. No adjustments have
been made to the carrying amounts of assets or liabilities should the Company be required to liquidate
after November 15, 2025.2026. The financial
statements do not include any adjustment that might be necessary if the Company is unable to continue
as a going concern.
For the year ended December 31, 2025, we had a net loss of approximately $1,300,000, which consisted of loss from the change in fair value of derivative liabilities of approximately $470,000, interest expense - debt issuance cost of approximately $78,000, loss from the change in fair value of contingently issuable private placement warrants of approximately $24,000, and general and administrative expenses, including related party, of approximately $956,000, offset by investment income on the Trust Account of approximately $196,000.
For the year ended December
31, 2023, we had a net income of approximately $7.6 million, which consisted of investment income on the Trust Account of approximately
$5.4 million, gain from the change in fair value of derivative liabilities of approximately $2.1 million, gain from change in fair value
of contingently issuable private placement warrants of approximately $1.1 million, gain on extinguishment of forward purchase agreement
of approximately $0.3 million, gain on forgiveness of legal fees of approximately $19,000, and gain from the change in fair value of convertible
note to related party of approximately $800, partially offset by general and administrative expenses of approximately $969,000, general
and administrative expenses to related party of $350,000 and loss on conversion of note to contingently issuable private placement warrants
of approximately $69,000.
Contractual Obligations
Registration Rights and Shareholder Rights
The holders of Class B ordinary shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Class B ordinary shares), were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the consummation of the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Class A Ordinary Shares Subject to Possible
Redemption
We account for our Class
A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to
mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A
ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder or
subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all
other times, Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption
rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of December
31, 2024 and 2023, 455,736 and 4,151,134, respectively, Class A ordinary shares subject to possible redemption are presented at redemption
value as temporary equity, outside of the shareholders’ deficit section of our balance sheets, respectively.
We recognize changes in redemption
value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal
the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the
redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment
option), we recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in
capital (to the extent available) and accumulated deficit.
Net Income (Loss) Per Share
We comply with accounting
and disclosure requirements of ASC Topic 260. We have two classes of shares, which are referred to as Class A ordinary shares and Class
B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated
by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period.
The calculation of diluted net income does not consider the effect
of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the over-allotment) and the Private
Placement Warrants to purchase an aggregate of 23,200,000 Class A ordinary shares in the calculation of diluted income per share, because
their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic
net income per share for the year ended December 31, 2024 and 2023. Accretion associated with the redeemable Class A ordinary shares is
excluded from earnings per share as the redemption value approximates fair value.
We have considered the effect
of Class B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option
by the underwriters. Since the contingency was satisfied, we have included these shares in the weighted average number as of the beginning
of the period to determine the dilutive impact of these shares.
In December 2023, the FASB issued
issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental
income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements.
ASU 2023-09 is effective for fiscal years beginning after December 15, 2025. Early adoption is permitted. The Company’sCompany managementadopted ASU 2023-09
does not believefor the fiscal year beginning January 1, 2026. The adoption of ASU 2023-09 willdid not have a material impact on itsthe Company’s financial
statements andor related disclosures.
As of December 31, 2024 and
2023,2025, we did
not have any off-balance sheet arrangements as defined in Item 303(ab)(41)(ii)(B) of Regulation S-K.
What changed in the latest 10-Q
Risk Factors
Factors that could cause our actual results to differ materially from those in this Quarterly Report on Form 10-Q include the risk factors described in our Annual Report on Form 10-K filed with the SEC on April 1, 2026. You should review the risk factors described in our Annual Report on Form 10-K filed with the SEC on April 1, 2026 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in this Quarterly Report on Form 10-Q. If any of the risks described in our Annual Report on Form 10-K filed with the SEC on April 1, 2026 actually occur, our business, financial condition and results of operations could be adversely affected.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Removed heading “Contractual Obligations”
Removed heading “Registration Rights and Shareholder Rights”
Largest changes
On September 30, 2025, the Company issued an unsecured, non-interest bearing promissory note (the “C/M Note”) to the C/M C/M Lender in the aggregate principal amount of $1,250,000, for an aggregate purchase price of $1,000,000. The C/M Note is due and payable in full on the maturity date, June 30, 2026; provided that, upon the occurrence of an event of default, the outstanding principal and any other amounts outstanding under the C/M Note will become due and payable without demand. The C/M Note may be prepaid at any time without penalty. All payments due under the C/M Note rank junior to certain existing indebtedness of the Company and senior to all other indebtedness of the Company and its subsidiaries. The proceeds of the C/M Note will be used to pay for certain fees and expenses incurred in connection with the Company’s initial Business Combination and for other general corporate purposes.see in full comparisonAsOn May 28, 2026, the Company entered into Amendment No. 1 to the Note. Pursuant to Amendment No. 1, among other things, (i) the maturity date ofMarchthe31,Note was extended from June 30, 2026 to November 15, 2026 andDecember 31, 2025, the outstanding balance under(ii) theC/MeventNoteof default for failure to establish and authorize a certificate of designation for a new series of preferred shares of the Company on or before November 15, 2025 was$1,160,397 and $1,078,066, respectively, in the accompanying balance sheets.removed.
“The holders of Class B ordinary shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Class B ordinary shares), were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the consummation of the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. …”see in full comparison
“For the three months ended March 31, 2026, we had a net loss of approximately $437,000, which consisted of loss from the change in fair value of derivative liabilities of approximately $104,000, interest expense - debt issuance cost of approximately $82,000, loss from the change in fair value of contingently issuable private placement warrants of approximately $5,000, and general and administrative expenses of approximately $222,000 and general and administrative expenses to related party of $30,000, offset by income from investments held in Trust Account of approximately $7,000.”see in full comparison
“For the six months ended June 30, 2026, we had a net loss of approximately $603,000, which consisted of loss from the change in fair value of derivative liabilities of approximately $37,000, interest expense - debt issuance cost of approximately $183,000, loss from the change in fair value of contingently issuable private placement warrants of approximately $2,000, and general and administrative expenses of approximately $334,000 and general and administrative expenses to related party of $60,000, offset by income from investments held in Trust Account of approximately $14,000.”see in full comparison
Full comparison: every changed paragraph (16)
As of MarchJune 31,
30, 2026, we
had cash of $136,637$147,356 and working capital deficit of $1,060,576.$952,568.
On May 9, 2024,
the Company
entered into the Exchange Agreement with Fulton, pursuant to which Fulton and the Company agreed to Exchange the Fulton AC
Note for the
Exchange Note. The Exchange Note is substantially similar to the Fulton AC Note, except that (i) the governing law and jurisdiction was
was changed from New York to Delaware; (ii) the maturity date was extended to the later of (x) June 29, 2025 and (y) the consummation of
of the Company’s initial Business Combination; and (iii) the holder may exchange the Exchange Note, in whole or in part, to satisfy
the purchase price of securities sold by the Company in a subsequent offering, if any, in whole or in part, at a premium of 35%. At this
time the Company does not have any agreements, written or oral, for any subsequent offering of Company securities. No new consideration
was paid in conjunction with the Exchange. As of MarchJune 31,30, 2026 and December 31, 2025, the Company has an outstanding balance of $368,680
under the Exchange Note.
On June 26, 2024, Phytanix
Phytanix Bio (“Phytanix”) agreed to loan the Company $1,590,995, pursuant to an unsecured non - interest bearing promissory
note (the
“Bridge Financing Note”). The maturity date of the Bridge Financing Note is the later of (x) June 29, 2025 and
(y) the consummation
of the Company’s initial Business Combination. The Bridge Financing Note may not be repaid with funds from
the trust account that
the Company established for the benefit of its public holders. The proceeds from the Bridge Financing Note will
be used (i) to pay off
certain working capital loans issued by the Company to Fulton AC, (ii) to pay for certain fees and expenses incurred
in connection with
the transactions contemplated in the Bridge Financing Note and the Company’s initial Business Combination and
(iii) for other general
corporate purposes. As of MarchJune 31,30, 2026 and December 31, 2025, the outstanding balance under the Bridge Financing
Note was $1,023,235
in the accompanying balance sheets.
On September 30,
2025, the Company issued an
unsecured, non-interest bearing promissory note (the “C/M Note”) to the C/M C/M Lender in the
aggregate principal amount
of $1,250,000, for an aggregate purchase price of $1,000,000. The C/M Note is due and payable in full on the
maturity date, June 30,
2026; provided that, upon the occurrence of an event of default, the outstanding principal and any other amounts
outstanding under the
C/M Note will become due and payable without demand. The C/M Note may be prepaid at any time without penalty. All
payments due under
the C/M Note rank junior to certain existing indebtedness of the Company and senior to all other indebtedness of the
Company and its
subsidiaries. The proceeds of the C/M Note will be used to pay for certain fees and expenses incurred in connection with
the Company’s
initial Business Combination and for other general corporate purposes. AsOn May 28, 2026, the Company entered into Amendment No. 1 to the
Note. Pursuant to Amendment No. 1, among other things, (i) the maturity date of Marchthe 31,Note was extended from June 30, 2026 to November
15, 2026 and December 31, 2025,
the outstanding balance under(ii) the C/Mevent Noteof default for failure to establish and authorize a certificate of designation for a new series of preferred
shares of the Company on or before November 15, 2025 was $1,160,397 and $1,078,066, respectively, in the accompanying balance sheets.removed.
As of June 30, 2026 and December 31, 2025, the outstanding balance under the C/M Note was $1,511,255 and $1,078,066, respectively, in the accompanying balance sheets.
Our entire activity since
since inception up to MarchJune 31,30, 2026 was in preparation for our Initial Public Offering and since the closing of the Initial Public Offering,
the search for a prospective Business Combination. We will not generate any operating revenues until the closing and completion of our
initial Business Combination, at the earliest.
For the three months
ended March 31, 2026, we had a net loss of approximately $437,000, which consisted of loss from the change in fair value of derivative
liabilities of approximately $104,000, interest expense - debt issuance cost of approximately $82,000, loss from the change in fair value
of contingently issuable private placement warrants of approximately $5,000, and general and administrative expenses of approximately
$222,000 and general and administrative expenses to related party of $30,000, offset by income from investments held in Trust Account
of approximately $7,000.
For the three months ended
endedJune March30, 31, 2025,2026, we had a net loss of approximately $364,000,$166,000, which consisted of interest expense - debt issuance cost of $101,000, general
and administrative expenses of approximately
$192,000$112,000 and general and administrative expenses to related party of $30,000, offset by income from investment investments
held in Trust Account
of approximately $55,000,$7,000, gain from the change in fair value of derivative liabilities of approximately $187,000 $66,000,
and gain from the change
in fair value of contingently issuable private placement warrants of approximately $10,000.$3,000.
For the three months ended June 30, 2025, we had a net income of approximately $5,800, which consisted of investment income on the Trust Account of approximately $56,000, gain from the change in fair value of derivative liabilities of approximately $242,000 and gain from the change in fair value of contingently issuable private placement warrants of approximately $13,000, offset by general and administrative expenses of approximately $275,000 and general and administrative expenses to related party of $30,000.
For the six months ended June 30, 2026, we had a net loss of approximately $603,000, which consisted of loss from the change in fair value of derivative liabilities of approximately $37,000, interest expense - debt issuance cost of approximately $183,000, loss from the change in fair value of contingently issuable private placement warrants of approximately $2,000, and general and administrative expenses of approximately $334,000 and general and administrative expenses to related party of $60,000, offset by income from investments held in Trust Account of approximately $14,000.
For the six months ended June 30, 2025, we had a net loss of approximately $358,000, which consisted of general and administrative expenses of approximately $467,000 and general and administrative expenses to related party of $60,000, offset by investment income on the Trust Account of approximately $111,000, gain from the change in fair value of derivative liabilities of approximately $55,000 and gain from the change in fair value of contingently issuable private placement warrants of approximately $3,000.
The 22,050,000 warrants
that were issued in connection with the Initial Public Offering (including the 11,500,000 warrants included in the Units and the 10,550,000
Private Placement Warrants) and the 4,000,000 Forward Purchase Securities, were recognized as derivative liabilities in accordance with
ASC Topic 815. Accordingly, the Company recognized the warrant instruments as liabilities at fair value and adjust the instruments to
fair value at each reporting period. The liabilities will be subject to re-measurement at each balance sheet date until exercised. The
fair value of the Forward Purchase Securities, Public Warrants and the Private Placement Warrants were initially measured using a Monte
Carlo simulation. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured
based on the listed market price of such Public Warrants. On December 26, 2023, in connection with the Securities Purchase Agreement,
the Forward Purchase Securities were terminated and the Convertible Note was converted into contingently issuable private placement warrants.
As of MarchJune 31,30, 2026 and December 31, 2025, the fair value of Private Placement Warrants was determined based on the quoted price of the
the Public Warrants.
Contractual Obligations
Registration Rights and Shareholder Rights
The holders of Class
B ordinary shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares
of ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital
Loans and upon conversion of the Class B ordinary shares), were entitled to registration rights pursuant to a registration and shareholder
rights agreement signed upon the consummation of the Initial Public Offering. These holders will be entitled to certain demand and “piggyback”
registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
As of MarchJune 31,
30, 2026, we
did not have any off-balance sheet arrangements as defined in Item 303(b)(1)(ii)(B) of Regulation S-K.
CBRRF insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding CBRRF (13F)
None of the 59 investors we track reported a position in their latest 13F.